Iowa HSB 164: A bill for an act relating to the medical use of cannabidiol including the rescheduling of a cannabidiol investigational product approved as a prescription drug medication under federal law and including effective date provisions. (See HF 520.)

Status: Subcommittee recommends passage. (as of 2018-02-06)

State: Iowa · Session: 2017-2018 · Bill: HSB 164

Subjects: controlled substances, drugs, marijuana, pharmacy, prescription drugs

Sponsors: COMMITTEE ON PUBLIC SAFETY

View Iowa HSB 164 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.